How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend?Motley Fool·Jul 19 at 08:05 PMABBV-0.94%APGE0.00%
Marks Group Wealth Management Inc Takes $694,000 Position in Apogee Therapeutics Inc. $APGEMarket Beat·Jul 17 at 04:37 AMAPGE0.00%
16:00 ET$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CRBG, RMAX, GBCS, and APGEprnewswire·Jul 14 at 03:00 PMAPGE0.00%CRBG+1.41%
AbbVie extends slide to a seventh straight sessionbusinessinsider·Jul 14 at 01:00 PMABBV-0.94%APGE0.00%
AbbVie is already a dividend king. Here's why the $10.9 billion Apogee deal could make it a dynastyMSN·Jul 11 at 08:35 PMAPGE0.00%ABBV-0.94%
Apogee Therapeutics CEO Michael Thomas Henderson disposes of USD 2.67 million in common sharesPUBT·Jul 10 at 07:01 PMAPGE0.00%
Apogee Therapeutics (NASDAQ:APGE) Reaches New 52-Week High - Here's WhyMarket Beat·Jul 8 at 04:40 AMAPGE0.00%
14:18 ET$HAREHOLDER ALERT: The M&A Class Action Firm Continues to Investigate the Merger--AVB, APGE, TMHC, and LPROprnewswire·Jul 6 at 01:19 PMAVB-1.08%TMHC0.00%
Apogee Therapeutics rises 1% to record high on AbbVie deal probeUS Stock Market Update·Jul 6 at 04:34 PMAPGE0.00%
